Insulinomas in particular exhibit receptors such as the growth inhibitory receptor 2 (SSTR2) and the glucagon‐like peptide‐1 receptor (GLP‐1 receptor), with over 90% of these tumors expressing the GLP‐1 receptor. Here, SSTR2 is linked to pancreatic insulinoma.